cddis2017487.pdf (2.2 MB)
Download file

Molecular motion regulates the activity of the Mitochondrial Serine Protease HtrA2.

Download (2.2 MB)
journal contribution
posted on 21.11.2017, 11:35 by Matthew Merski, Cátia Moreira, Rui M. V. Abreu, Maria João Ramos, Pedro A. Fernandes, L. Miguel Martins, Pedro José Barbosa Pereira, Sandra Macedo-Ribeiro
HtrA2 (high-temperature requirement 2) is a human mitochondrial protease that has a role in apoptosis and Parkinson's disease. The structure of HtrA2 with an intact catalytic triad was determined, revealing a conformational change in the active site loops, involving mainly the regulatory LD loop, which resulted in burial of the catalytic serine relative to the previously reported structure of the proteolytically inactive mutant. Mutations in the loops surrounding the active site that significantly restricted their mobility, reduced proteolytic activity both in vitro and in cells, suggesting that regulation of HtrA2 activity cannot be explained by a simple transition to an activated conformational state with enhanced active site accessibility. Manipulation of solvent viscosity highlighted an unusual bi-phasic behavior of the enzymatic activity, which together with MD calculations supports the importance of motion in the regulation of the activity of HtrA2. HtrA2 is an unusually thermostable enzyme (TM=97.3 °C), a trait often associated with structural rigidity, not dynamic motion. We suggest that this thermostability functions to provide a stable scaffold for the observed loop motions, allowing them a relatively free conformational search within a rather restricted volume.

Funding

Funding to Biomolecular Structure and Function lab was provided by the project Norte-01-0145-FEDER-000008 – Porto Neurosciences and Neurologic Disease Research Initiative at I3S, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). CM, MJR and PAF acknowledge the financial support from the European Union (FEDER funds POCI/01/0145/FEDER/007728) and National Funds (FCT/MEC, Fundação para a Ciência e Tecnologia and Ministério da Educação e Ciência) under the Partnership Agreement PT2020 UID/MULTI/04378/2013. C.M. is a recipient of a FCT PhD fellowship (SFRH/BD/84016/2012). M.M. thanks the Fundação para a Ciência e a Tecnologia (FCT) for its support through the Ciência 2008 program.

History

Citation

Cell Death and Disease, 2017, 8 (10), e3119

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/MBSP Non-Medical Departments/Molecular & Cell Biology

Version

VoR (Version of Record)

Published in

Cell Death and Disease

Publisher

Nature Publishing Group for Associazione Differenziamento e Morte Cellulare

issn

2041-4889

eissn

2041-4889

Acceptance date

22/08/2017

Copyright date

2017

Available date

21/11/2017

Publisher version

https://www.nature.com/articles/cddis2017487

Notes

Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)

Language

en

Usage metrics

Categories

Keywords

Licence

Exports